The food industry is facing a significant shift as GLP-1 medications gain popularity. According to Food Industry Executive, approximately 11 per cent of adults in the US have adopted these drugs, leading to a reduction in overall grocery expenditure.
This change in consumer behaviour poses a substantial financial risk to major brands, with an estimated 73 billion dollars in food brand value at stake. While some companies restructure to adapt, others are focusing on infrastructure, such as Coca-Cola investing 10 billion dollars into US manufacturing.
Adding to these pressures is a complex inflation landscape. Although headline food inflation sits at 1.3 per cent, the actual costs of production are climbing. Input costs for grains have risen by 17.7 per cent and diesel has jumped 77.8 per cent, with El Niño weather patterns creating further risks for the sector.